Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

123.96 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nuvalent, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity ↗

September 16, 2024

Nuvalent presented updated Phase 1 data from its ARROS-1 and ALKOVE-1 trials at the ESMO Congress 2024. Key data showed promising response rates in pretreated patients, with pivotal results expected in...

Via Benzinga

Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths ↗

September 16, 2024

Nuvalent and Iteos delivered promising updates in their lung cancer studies. But three patients died in one test.

Via Investor's Business Daily

Topics Death

Crude Oil Surges Over 1%; Instil Bio Shares Plunge ↗

September 16, 2024

Via Benzinga

Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday ↗

September 16, 2024

Via Benzinga

Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio? ↗

August 25, 2024

Via Benzinga

NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024 ↗

August 08, 2024

NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024 ↗

May 09, 2024

NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally ↗

June 24, 2024

Although short-squeeze stocks to buy present great risk, betting against the bears can also yield dramatically robust returns.

Via InvestorPlace

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗

June 09, 2024

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

Via Benzinga

Recap: Nuvalent Q4 Earnings ↗

February 27, 2024

Via Benzinga

Recap: Nuvalent Q3 Earnings ↗

November 14, 2023

Via Benzinga

7 Biotech Stocks to Get In Now Before Investors Catch On ↗

October 23, 2023

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

Via InvestorPlace

Where Nuvalent Stands With Analysts ↗

October 05, 2023

Via Benzinga

Why Nuvalent Stock Was Soaring Wednesday ↗

October 04, 2023

The company reported preliminary data on a non-small cell lung cancer therapy.

Via The Motley Fool

Expert Ratings for Nuvalent ↗

August 08, 2023

Via Benzinga

Nuvalent: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Why Nuvalent Stock Tanked on Tuesday ↗

October 17, 2023

The dilution monster stalked the company following the announcement of a new capital-raising effort.

Via The Motley Fool

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

October 06, 2023

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...

Via Benzinga

Why Nuvalent Stock Skyrocketed 35% This Week ↗

October 05, 2023

Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 04, 2023

Via Benzinga

Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold ↗

September 27, 2023

Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 18, 2023

Gainers

Via Benzinga

Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗

September 18, 2023

U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

7 A-Rated Biotech Stocks for Your August Buy List ↗

August 17, 2023

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying ↗

November 08, 2022

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying ↗

November 04, 2022

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗

January 18, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.